new chemo regimen helps children with neuroblastoma
Last Updated : GMT 06:49:16
Arab Today, arab today
Arab Today, arab today
Last Updated : GMT 06:49:16
Arab Today, arab today

New chemo regimen helps children with neuroblastoma

Arab Today, arab today

Arab Today, arab today New chemo regimen helps children with neuroblastoma

Chicago - AFP

A new high-dose chemotherapy regimen has been shown to improve survival of children with high-risk neuroblastoma, a common pediatric cancer, according to a European clinical trial. "The study's results are important for patients with this extremely difficult to treat disease," said lead author Ruth Ladenstein of the University of Vienna and St. Anna Children's Cancer Research Institute in Vienna, Austria. The results were presented in Chicago at the 47th annual conference of the American Society of Clinical Oncology. More than 30,000 researchers and representatives of pharmaceutical companies participated in the forum. The phase 3 trial showed better overall survival with a combination of the myeloablative chemotherapy drugs busulphan and melphalan (BuMel) compared to a different myeloablative regimen of three chemotherapy drugs, carboplatin, etoposide and melphalan (CEM). Previously, only 30 percent of children with high-risk neuroblastoma survive long-term. The study's results show that survival can increase by 20 percent. "We could potentially improve overall prognosis by up to 35 percent in the future," Ladenstein said. "Thus, we overcome the 50 percent threshold in survival rates by choosing the right high-dose myeloablative regimen for these patients," she added. Myeloablative chemotherapy is high-dose chemotherapy that kills cells in the bone marrow, including cancer cells. Neuroblastoma is rare, but is the most common cancer in the first year of life and accounts for approximately 15 percent of childhood cancer deaths. About 650 cases are diagnosed each year in the United States, with 40 percent considered high-risk, meaning they are "very likely to recur or progress, despite therapy," the study said. The trial involved 563 children -- median age 3. After three years, the survival was 60 percent for those receiving busulphan-melphalan compared to 48 percent for the CEM group "and the busulphan group had lower rates of relapse and progression." "Based on the results, the randomization was stopped early," the study said. The treatment-related death rate was 3 percent for the busulphan regimen and 5 percent for CEM, the study said.

arabstoday
arabstoday

Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

new chemo regimen helps children with neuroblastoma new chemo regimen helps children with neuroblastoma

 



Name *

E-mail *

Comment Title*

Comment *

: Characters Left

Mandatory *

Terms of use

Publishing Terms: Not to offend the author, or to persons or sanctities or attacking religions or divine self. And stay away from sectarian and racial incitement and insults.

I agree with the Terms of Use

Security Code*

new chemo regimen helps children with neuroblastoma new chemo regimen helps children with neuroblastoma

 



GMT 09:37 2012 Saturday ,28 April

Asamoah Gyan celebrates UAE title

GMT 06:57 2017 Tuesday ,12 December

Latest Grateful Dead resurrection -- a duo

GMT 14:03 2017 Friday ,10 February

3 Chinese miners killed in accident in Albania

GMT 10:06 2018 Sunday ,14 January

Qanso, Kijian tackle recent developments

GMT 18:58 2017 Saturday ,04 March

Gold prices continue to fall

GMT 12:49 2017 Thursday ,24 August

Fadl Shaker could be arrested soon

GMT 02:06 2017 Monday ,30 October

May22/Jun21

GMT 22:28 2017 Thursday ,24 August

February20th-March20th

GMT 08:07 2017 Saturday ,18 November

BBA President visits BHA

GMT 02:27 2017 Saturday ,28 October

September24th-October23rd

GMT 14:20 2017 Saturday ,26 August

Former VW engineer gets 40 months
Arab Today, arab today
 
 Arab Today Facebook,arab today facebook  Arab Today Twitter,arab today twitter Arab Today Rss,arab today rss  Arab Today Youtube,arab today youtube  Arab Today Youtube,arab today youtube

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©

arabstoday arabstoday arabstoday arabstoday
arabstoday arabstoday arabstoday
arabstoday
بناية النخيل - رأس النبع _ خلف السفارة الفرنسية _بيروت - لبنان
arabstoday, Arabstoday, Arabstoday